quarta-feira, 7 de outubro de 2026
PesquisarExplore
pt.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 23, 2026

New Crypto: Pepeto Presale Stage Update While Dogecoin Price Prediction Heats Up After Elon Musk Dogefather Post and Shiba Inu Pattern Returns

View original at globenewswire.com
New Crypto: Pepeto Presale Stage Update While Dogecoin Price Prediction Heats Up After Elon Musk Dogefather Post and Shiba Inu Pattern Returns Dubai, UAE, March 22, 2026 (GLOBE NEWSWIRE) -- Pepeto confirms the fund just passed $8.28 million after the sell out of the last stage, this new crypto presale is filling faster…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The dogecoin price prediction for $1 requires $140 billion market cap which analysts say Dogecoin cannot hold without utility

    60% confidence

  • There are some Elon Musk connections to Pepeto growing across crypto communities now, adding the same attention that made Dogecoin explode

    60% confidence

  • Every bull market in crypto produces new millionaires, and they almost always come from the same place: meme coin presales that hit at the right time

    60% confidence

  • Pepeto's exchange runs a zero fee execution layer with native cross chain settlement and AI contract scanning across Ethereum, BNB Chain, and Solana, giving the meme coin market trading tools it never had before

    60% confidence

  • Pepeto offers presale entry into a verified DeFi exchange with viral community demand, making it the new crypto that Shiba Inu and Dogecoin investors wish existed at this stage

    60% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
A nossa leitura dos dados ›
Sinais que acompanhamos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,985
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,985 factos verificados com a fonte5,351 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
New Crypto: Pepeto Presale Stage Update While Dogecoin Price Prediction Heats Up After Elon Musk Dogefather Post and Shiba Inu Pattern Returns — Source | Via News | pt.VIA.NEWS